Dana-Farber research uncovered the potential for underdiagnosis of this aggressive cancer and identified additional tests ...

Dr. Shuch and Dr. Calais have opened the CA NINE trial, which is a prospective comparison of contrast-enhanced CT against 89 Zr-TLX250 PET for the imaging-based detection of recurrent clear cell renal ...

Adding casdatifan to Cabometyx therapy showed encouraging activity and was generally well tolerated in previously treated ...

Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...

Levels of kidney injuring molecule–1 appear to be predictive of therapeutic benefit in patients with renal cell carcinoma.

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...

Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell ...